KEWAUNEE SCIENTIFIC CORP /DE/
KEQU · XNASCIK 55529fmd_1NCFHV73902P2DVN2TDVSMDHNGManufacturing · Laboratory Apparatus & FurnitureTemplate: Standard
Coverage: May 01, 2009 to Jul 31, 2026, 66 periods
Latest annual · FY2026
Millions- Total revenues
- 282
- Gross profit
- 80
- Operating income
- 17
- Net income
- 10
- Free cash flow
- 15
Latest quarter · Q1 FY2027
Millions- Total revenues
- 66
- Gross profit
- 20
- Operating income
- 3
- Net income
- 2
- Free cash flow
- 1
Daily close · KEQUIEX trades only
Mar 28, 2024 to Nov 05, 2026 · 250 sessions34.52 USD
Built from trades executed at IEX only, one exchange with a small share of US volume. This is not the consolidated tape. The close is the last IEX trade of the session, not the official closing price. Earlier sessions are divided by the later split ratios the API confirmed against IEX prices; dividends are not adjusted. Switch to As traded for the prices as they printed. End of day, not real time: a session is published the day after it trades.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2023 to FY2026
- +8.7%
- Revenue, 5 yearsFY2021 to FY2026
- +13.8%
- Net income, 5 yearsFY2021 to FY2026
- n/m
KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2026 | FY2025 | Change | Source |
|---|---|---|---|---|
| Revenue | $282 million | $240.5 million | +17.3% | 10-K 2026-06-26 · proof |
| Gross profit | $80.4 million | $68.9 million | +16.8% | 10-K 2026-06-26 · proof |
| Operating income | $16.7 million | $17.8 million | -5.9% | 10-K 2026-06-26 · proof |
| Net income | $9.6 million | $11.4 million | -15.7% | 10-K 2026-06-26 · proof |
| Cash from operating activities | $18.6 million | $14.8 million | +26% | 10-K 2026-06-26 · proof |
| Free cash flow | $14.7 million | $12.6 million | +16.5% | 10-K 2026-06-26 · proof |
| Total assets | $178.3 million | $194.7 million | -8.4% | 10-K 2026-06-26 · proof |
| Total liabilities | $101.5 million | $128.4 million | -21% | 10-K 2026-06-26 · proof |
| Cash and cash equivalents | $10 million | $14.9 million | -33.4% | 10-K 2026-06-26 · proof |
| Total debt | $20.1 million | $38.7 million | -48.1% | 10-Q 2026-09-11 · proof |
- What was KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)'s revenue in fiscal 2026?
- KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) reported revenue of $282 million for fiscal 2026 (the year ended Apr 30, 2026), against $240.5 million the year before (+17.3%). Source: the 10-K filed with the SEC on Jun 26, 2026. SEC
- What was KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)'s gross profit in fiscal 2026?
- KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) reported gross profit of $80.4 million for fiscal 2026 (the year ended Apr 30, 2026), against $68.9 million the year before (+16.8%). Source: the 10-K filed with the SEC on Jun 26, 2026. SEC
- What was KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)'s operating income in fiscal 2026?
- KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) reported operating income of $16.7 million for fiscal 2026 (the year ended Apr 30, 2026), against $17.8 million the year before (-5.9%). Source: the 10-K filed with the SEC on Jun 26, 2026. SEC
- What was KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)'s net income in fiscal 2026?
- KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) reported net income of $9.6 million for fiscal 2026 (the year ended Apr 30, 2026), against $11.4 million the year before (-15.7%). Source: the 10-K filed with the SEC on Jun 26, 2026. SEC
- What was KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)'s cash from operating activities in fiscal 2026?
- KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) reported cash from operating activities of $18.6 million for fiscal 2026 (the year ended Apr 30, 2026), against $14.8 million the year before (+26%). Source: the 10-K filed with the SEC on Jun 26, 2026. SEC
- What was KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)'s free cash flow in fiscal 2026?
- KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) reported free cash flow of $14.7 million for fiscal 2026 (the year ended Apr 30, 2026), against $12.6 million the year before (+16.5%). Source: the 10-K filed with the SEC on Jun 26, 2026. SEC
- What are KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)'s total assets?
- As of Apr 30, 2026, KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) reported total assets of $178.3 million, against $194.7 million a year earlier (-8.4%). Source: the 10-K filed with the SEC on Jun 26, 2026. SEC
- What are KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)'s total liabilities?
- As of Apr 30, 2026, KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) reported total liabilities of $101.5 million, against $128.4 million a year earlier (-21%). Source: the 10-K filed with the SEC on Jun 26, 2026. SEC
- What are KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)'s cash and cash equivalents?
- As of Apr 30, 2026, KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) reported cash and cash equivalents of $10 million, against $14.9 million a year earlier (-33.4%). Source: the 10-K filed with the SEC on Jun 26, 2026. SEC
- What is KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)'s total debt?
- As of Apr 30, 2026, KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) reported total debt of $20.1 million, against $38.7 million a year earlier (-48.1%). Source: the 10-Q filed with the SEC on Sep 11, 2026 (restated). SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:KEQU&period_type=annual&limit=5"Information only, not investment advice.